GSE233679 5 V 1 NICOTINAMIDE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE233679 5 V 1 NICOTINAMIDE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE233679 5 V 1 NICOTINAMIDE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE233679 5 V 1 NICOTINAMIDE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE233679 5 V 1 NICOTINAMIDE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

NBPF member 26

Gene

notch 2 N-terminal like R

Gene

corin, serine peptidase

Gene

PHD finger protein 12

Gene

zinc finger CCCH-type containing 13

Gene

synaptotagmin 12

Gene

protein kinase, membrane associated tyrosine/threonine 1

Gene

EP300 interacting inhibitor of differentiation 1

Gene

mitochondrial ribosomal protein L51

Gene

nuclear transcription factor Y subunit alpha


  • Gene

    notch 2 N-terminal like R


  • Gene

    corin, serine peptidase


  • Gene

    PHD finger protein 12


  • Gene

    zinc finger CCCH-type containing 13


  • Gene

    synaptotagmin 12


  • Gene

    protein kinase, membrane associated tyrosine/threonine 1


  • Gene

    EP300 interacting inhibitor of differentiation 1


  • Gene

    mitochondrial ribosomal protein L51


  • Gene

    nuclear transcription factor Y subunit alpha

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.